P Brücke, E Dienstl, H Vinazzer, W Simma. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedDihydroergotamine/administration & dosageDrug Therapy, CombinationFemaleHeparin/administration & dosageHeparin/adverse effectsHumansMaleMiddle AgedPostoperative Complications/prevention & controlThromboembolism/prevention & control
Substances: See more » DihydroergotamineHeparin
Year: 1983 PMID: 6845285 DOI: 10.1016/0049-3848(83)90049-x
Source DB: PubMed Journal: Thromb Res ISSN: 0049-3848 Impact factor: 3.944